TrialYonsei medical journal2023

Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy.

Seung-Hyun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.